|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
SOMAPACITAN |
H01AC07 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005030 |
31-03-2021 |
VALID
|
|
TAGRAXOFUSP |
L01XX67 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005031 |
07-01-2021 |
VALID
|
|
LUMASIRAN |
A16AX18 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/005040 |
19-11-2020 |
VALID
|
|
SETMELANOTIDE |
A08AA12 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005089 |
16-07-2021 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005095 |
25-05-2022 |
VALID
|
|
FILGOTINIB |
L04AF04 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/005113 |
24-09-2020 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
TRASTUZUMAB DERUXTECAN |
L01FD04 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005124 |
18-01-2021 |
VALID
|
|
BEROTRALSTAT |
B06AC06 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005138 |
30-04-2021 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
PONESIMOD |
L04AE04 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005163 |
19-05-2021 |
VALID
|
|
OBILTOXAXIMAB |
J06BC04 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/005169 |
18-11-2020 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
TIRBANIBULIN |
D06BX03 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005183 |
16-07-2021 |
VALID
|
|
FINERENONE |
C03DA05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005200 |
16-02-2022 |
VALID
|
|
DOSTARLIMAB |
L01FF07 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005204 |
21-04-2021 |
VALID
|
|
BUPIVACAINE AND MELOXICAM |
N01BB59 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/005205 |
24-09-2020 |
VALID
|
|
AVAPRITINIB |
L01EX18 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/005208 |
24-09-2020 |
VALID
|
|
REMIMAZOLAM |
N05CD14 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005246 |
26-03-2021 |
VALID
|
|
TRALOKINUMAB |
D11AH07 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005255 |
17-06-2021 |
VALID
|
|
VOCLOSPORIN |
L04AD03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005256 |
15-09-2022 |
VALID
|
|
TUCATINIB |
L01EH03 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005263 |
11-02-2021 |
VALID
|
|
LONAFARNIB |
A16AX20 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005271 |
18-07-2022 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
ACALABRUTINIB |
L01EL02 |
PT
|
POM
|
26-01-2021 |
EMEA/H/C/005299 |
05-11-2020 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
BIMEKIZUMAB |
L04AC21 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005316 |
20-08-2021 |
VALID
|
|
VERICIGUAT |
C01DX22 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005319 |
16-07-2021 |
VALID
|
|
ATIDARSAGENE AUTOTEMCEL |
A16AB21 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005321 |
17-12-2020 |
VALID
|
|
LASMIDITAN |
N02CC08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005332 |
17-08-2022 |
VALID
|
|
DROSPIRENONE AND ESTETROL |
G03AA18 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005336 |
19-05-2021 |
VALID
|
|
RELUGOLIX |
L02BX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
LONAPEGSOMATROPIN |
H01AC09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005367 |
11-01-2022 |
VALID
|
|
SELPERCATINIB |
L01EX22 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005375 |
11-02-2021 |
VALID
|
|
FOSDENOPTERIN |
A16AX19 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005378 |
15-09-2022 |
VALID
|
|
DUVELISIB |
L01EM04 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005381 |
19-05-2021 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
OFATUMUMAB |
L04AG12 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005410 |
26-03-2021 |
VALID
|
|
PRALSETINIB |
L01EX23 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005431 |
21-03-2024 |
VALID
|
|
TAFASITAMAB |
L01FX12 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005436 |
26-08-2021 |
VALID
|
|
LINZAGOLIX |
H01CC04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005442 |
14-06-2022 |
VALID
|
|
EVINACUMAB |
C10AX17 |
PT
|
POM
|
13-10-2021 |
EMEA/H/C/005449 |
17-06-2021 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
TOFERSEN |
N07XX22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005493 |
29-05-2024 |
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|